Jeffrey Eisele - Chief Development Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jeffrey Eisele - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Jeffrey Eisele for Apellis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 57.2K $3.75M $65.53 Jan 30, 2024 Direct
Stock Option (Right to Buy) 28.4K $1.88M $66.30 Jan 16, 2024 Direct Common Stock

Transactions reported by Jeffrey Eisele for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.